Interim trial data from the US, Chile, and Peru have shown that Oxford-AstraZeneca’s covid vaccine is safe and highly effectiveReuters reports, citing the Oxford University statement.
Additional comments:
“The phase 3 study of the Oxford-AstraZeneca coronavirus vaccine conducted by AstraZeneca Plc in the US, Chile and Peru has shown that the vaccine is safe and highly effective“.
“The phase III vaccine trial in the US showed a 79% efficacy in preventing symptomatic cases“.
“The vaccine has also been shown to be 100% effective in preventing serious illness, death and hospitalization“.
The Anglo-Swedish pharmaceutical company has published data from a study of more than 30,000 volunteers.
.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
